Periodic Reporting for period 2 - Trep-AB (Repurposing clinically approved antibacterial drugs for treponematoses therapy)

Summary
Current therapeutic options for human treponematoses, syphilis and yaws, are, broadly speaking, restricted to one antibiotic: injectable penicillin. The drug susceptibility profile of Treponema pallidum (T.p) is unknown because the microorganism could not be grown in culture...
More information & hyperlinks